Human Upper Extremity Allotransplantation: Transplanted Patient Follow-Up Protocol
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Amputation, Traumatic
- Sponsor
- Johns Hopkins University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- QOL assessed for Hand Function by Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire
- Status
- Recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
Upper extremity allotransplantation is a new procedure which is becoming more common in the United States. Ongoing data collection for research purposes is vital to the long-term assessment as to the safety of the procedure and accompanying immunosuppression protocol, as well as quantifying patient outcomes and changes in quality of life. For these reasons, The Johns Hopkins Hand/Arm Transplantation Team is interested in enrolling transplanted patients in a follow-up protocol to continue collecting informative data to further the field of vascularized composite allotransplantation.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males and females 5 or more years post-unilateral or bilateral upper limb transplantation.
- •Completes the protocol informed consent form.
- •Consents to sample collection and storage (biopsies).
- •USA citizen or equivalent.
- •Patient agrees to comply with the protocol and states a dedication to the immunomodulatory treatment regime.
Exclusion Criteria
- •Candidate has not received an upper extremity allotransplant.
- •Any reason the study team thinks would cause the participant to be noncompliant or would put the patient at unacceptable risk if enrolled.
Outcomes
Primary Outcomes
QOL assessed for Hand Function by Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire
Time Frame: Change from baseline QOL at end of study (approximately 5 years post-enrollment (±90 days))
The DASH Outcome Measure is scored in two components: the disability/symptom section (30 items, scored 1-5) and the optional high performance Sport/Music or Work section (4 items, scored 1-5). 1 indicating no difficulty and 5 indicating unable perform the function.
QOL assessed by Lawton Instrumental Activities of Daily Living (ADL/IADL) Questionnaire
Time Frame: Change from baseline QOL at end of study (approximately 5 years post-enrollment (±90 days))
Questionnaire to asses Physical and instrumental activities for daily living. It contains 8 items that are rated with a summary score from 0 (low functioning) to 8 (high functioning). The scale will vary along a range of levels of competence- without any help, with some help, or does he need someone for the activities.
Psychological Measures by Satisfaction with Life Scale (SWLS)
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
SWLS is a measure of life satisfaction. Uses scale to rate from 1-7, Where 1 indicates Strongly disagree to 7 indicating strongly agree.
Psychological Measures assessed by NEO Five-Factor Inventory (NEO-FFI)
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
NEO-FFI is used to examine personality traits. Questions consists of 60 items. Items are scored from Strongly disagree to Strongly agreed
Quality of life (QOL) for upper extremity transplant recipients via Functional Assessment with rehabilitation using Carroll Test
Time Frame: Change from baseline QOL at end of study (approximately 5 years post-enrollment (±90 days))
Measures Grasp, Grip and Pinch Strength, Range of motion - Active \& Passive. During rehabilitation sessions in clinic using activities resembling everyday tasks such as pouring water, opening/closing zippers and buttons, lifting blocks of different weight. Carroll test contains 33 questions and is scored from 0-3, 0- can perform no part of test, 1- performs test partially, 2-completes test, but takes abnormally long time or has great difficulty, and 3- performs tests normally.
Quality of life assessed for Psychological Measures by Brief Symptom Inventory
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
Brief Symptom Inventory questionnaire evaluates psychological distress and psychiatric disorders. It consists of 53-item self-report inventory in which participants rate the extent to which they have been bothered. 5-point rating scale, 0 indicating not at all bothered to 4 extremely bothered.
Michigan Hand Outcomes Questionnaire
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
Monitor function, pain, work performance, and aesthetics of hand(s). Responses from 1-5, 1 being very good and 5 being very poor
Short Musculoskeletal Function Assessment (SMFA)
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
The SMFA consists of two sections: 34 questions covering the assessment of the patients function and 12 questions covering how bothered patients are by their symptoms. Each question is scored 1 for no problems/no difficulty/not bothered (depending on the question) to 5 for unable to do a task/symptoms all the time/being greatly bothered.
Psychological Measures assessed by Affect Balance Scale (ABS)
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
ABS is a 10-item questionnaire that assess positive and negative affect as indicators of life satisfaction and/or well-being. Score range from 0-4. 0 indicating the feeling never affected to 4, where the feeling is affected always.
Brief Pain Inventory (Short Form) (BPISF)
Time Frame: Change from baseline to end of study (approximately 5 years post-enrollment (±90 days))
BPISF assesses the severity of pain and its impact on functioning. It is scored from 0 to 10, 0 indicating no pain, does not interfere to 10 indicating pain as bad as you can imagine, completely interferes.
Secondary Outcomes
- Magnetic Resonance (MR) Neurography(Annually for 5 years (±90 days))
- Perform Skin Biopsy(Annually for 5 years (±90 days))
- Use CT Angiography(Annually for 5 years (±90 days))
- The efficacy of various immunosuppression regimens via ImmuKnow Assay/Cylex including immunomodulatory protocols (aka - Pittsburgh Protocol, Starzl Protocol), for maintenance of unilateral and bilateral upper extremity allotransplants.(Annually for 5 years post-enrollment (±90 days))
- Immunology- antibody testing by obtaining donor specific antibodies (DSA) by Luminex(Annually for 5 years (±90 days))